Business Insights
Completion Bias: The Psychology Behind Antibiotic Adherence
15 March 2024
By Leo Brown
How a simple change in pill presentation impacts medication compliance and its implications for public health.
Image: Roberto Sorin
In today's healthcare landscape, completing a full course of antibiotics is paramount for effective treatment and combatting the rising threat of antibiotic resistance. However, despite the clear importance of adherence, many patients struggle to complete their prescribed regimens. One intriguing aspect of this challenge lies in the psychology of medication compliance, particularly the phenomenon known as completion bias.
Completion bias refers to the tendency for individuals to perceive progress based on visual cues, which can significantly influence their behaviour. This phenomenon has been demonstrated in various contexts, including the adherence to antibiotic regimens. An illustrative example of completion bias in antibiotic adherence is the presentation of medication in different colours or formats.
Imagine a scenario where a patient is prescribed a course of antibiotics consisting of 20 white tablets and 4 blue tablets, with instructions to take the blue tablets after completing the white ones. Despite the fact that both the white and blue tablets contain the same active ingredient and are equally effective in treating the infection, patients are more likely to adhere to the regimen when presented with both colours of tablets. This seemingly minor change in pill presentation can trigger completion bias, leading patients to perceive progress and feel motivated to continue with the treatment until completion.
So, why does this happen? The answer lies in the way our brains process information and assess progress. Humans are wired to seek completion and closure, and visual cues play a significant role in signalling progress towards a goal. When patients see a mix of white and blue tablets, their brains interpret this as progress towards completing the treatment course, even though the chemical composition of the tablets remains unchanged.
This insight into completion bias has profound implications for healthcare providers and policymakers. By understanding the psychological mechanisms at play, healthcare professionals can design interventions to enhance medication adherence. Simple strategies such as altering pill presentation or providing visual progress indicators can leverage completion bias to improve patient engagement and adherence to treatment regimens.
Moreover, recognizing completion bias highlights the importance of personalized healthcare interventions. What works for one patient may not be effective for another, and understanding individual differences in perception and motivation is key to designing tailored interventions that resonate with patients.
In conclusion, completion bias offers valuable insights into the psychology of medication adherence. By acknowledging the influence of visual cues on behaviour, healthcare providers can design more effective interventions to promote adherence and improve patient outcomes. As we continue to navigate the challenges of antibiotic resistance and public health, leveraging completion bias represents a promising avenue for enhancing medication compliance and preserving the efficacy of these life-saving medications.